Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Cell Specific Gene Expression

Cell Specific Gene Expression

Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...

Regulation of Food Intake

Regulation of Food Intake

Short-term regulation of food intake primarily involves neural signals from the gastrointestinal (GI) tract, blood nutrient levels, and GI tract hormones. Communication between the gut and brain via vagal nerve fibers plays a significant role in evaluating the contents of the gut. Clinical studies have shown that protein ingestion produces a more prolonged response in these nerve fibers compared to an equivalent amount of glucose. Additionally, the activation of stretch receptors caused by GI...

Glucagon-like Receptor Agonists

Glucagon-like Receptor Agonists

Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by the...

Insulin: The Receptor and Signaling Pathways

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but this inhibition is released...

Insulin Secretory Vesicles

Insulin Secretory Vesicles

Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are co-secreted in...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Hypothalamic Leptin Gene Therapy Reduces Bone Marrow Adiposity in ob/ob Mice Fed Regular and High-Fat Diets.

Frontiers in endocrinology·2016

Same author

Hypothalamic leptin gene therapy reduces body weight without accelerating age-related bone loss.

The Journal of endocrinology·2015

Same author

Should leptin replace insulin as a lifetime monotherapy for diabetes type 1 and 2?

Indian journal of endocrinology and metabolism·2013

Same author

The effect of high fat diet and saturated fatty acids on insulin signaling in the amygdala and hypothalamus of rats.

Brain research·2013

Same author

PKCθ expression in the amygdala regulates insulin signaling, food intake and body weight.

Obesity (Silver Spring, Md.)·2013

Same author

A case for new therapy for diabetes, is it leptin?

Indian journal of endocrinology and metabolism·2013

Search research articles

Related Experiment Video

Updated: Jul 20, 2026

Hyperinsulinemic-euglycemic Clamps in Conscious, Unrestrained Mice

Hyperinsulinemic-euglycemic Clamps in Conscious, Unrestrained Mice

Published on: November 16, 2011

Hypothalamic clamp on insulin release by leptin-transgene expression.

Stéphane Boghossian¹, Michael G Dube, Rita Torto

¹Department of Neuroscience, University of Florida, McKnight Brain Institute, PO Box 100244, Gainesville, FL 32610-0244, USA.

|September 12, 2006

Summary

Sustained hypothalamic leptin action can control insulin secretion regardless of diet, offering a potential therapy for type 2 diabetes by managing insulin resistance and pancreatic insulin release.

More Related Videos

Hyperinsulinemic-Euglycemic Clamp in the Conscious Rat

Hyperinsulinemic-Euglycemic Clamp in the Conscious Rat

Published on: February 7, 2011

Hyperglycemic Clamp and Hypoglycemic Clamp in Conscious Mice

Hyperglycemic Clamp and Hypoglycemic Clamp in Conscious Mice

Published on: January 26, 2024

Related Experiment Videos

Last Updated: Jul 20, 2026

Hyperinsulinemic-euglycemic Clamps in Conscious, Unrestrained Mice

Hyperinsulinemic-euglycemic Clamps in Conscious, Unrestrained Mice

Published on: November 16, 2011

Hyperinsulinemic-Euglycemic Clamp in the Conscious Rat

Hyperinsulinemic-Euglycemic Clamp in the Conscious Rat

Published on: February 7, 2011

Hyperglycemic Clamp and Hypoglycemic Clamp in Conscious Mice

Hyperglycemic Clamp and Hypoglycemic Clamp in Conscious Mice

Published on: January 26, 2024

Area of Science:

Neuroendocrinology
Metabolic Disease Research
Molecular Biology

Background:

Leptin is a key hormone regulating energy balance and metabolism.
Dysregulation of leptin signaling is implicated in obesity and insulin resistance.
The hypothalamus plays a critical role in integrating metabolic signals.

Purpose of the Study:

To investigate the sustained effects of hypothalamic leptin on insulin secretion and fat accrual.
To examine the impact of leptin signaling on glucose tolerance and insulin response in different dietary contexts.
To explore the therapeutic potential of hypothalamic leptin for metabolic disorders.

Main Methods:

Intracerebroventricular (icv) injection of recombinant adeno-associated virus vector encoding leptin gene (rAAV-lep) in leptin-deficient ob/ob mice and rats.
Chronic high-fat diet (HFD) and regular chow diet (RCD) consumption.
Assessment of body weight, fat accumulation, insulin levels, and glucose tolerance.

Main Results:

Enhanced hypothalamic leptin expression suppressed weight gain, fat accumulation, hyperinsulinemia, and improved glucose tolerance in mice on RCD.
Hypothalamic leptin failed to suppress weight gain and fat accumulation in mice switched to HFD but maintained insulinopenia and glucose tolerance.
Leptin treatment in rats on RCD attenuated post-prandial insulin release, weight gain, and fat depots.

Conclusions:

Sustained hypothalamic leptin action can independently regulate pancreatic insulin secretion, irrespective of dietary fat content.
This suggests a stable mechanism for controlling insulin release and insulin resistance.
Targeting hypothalamic leptin signaling presents a potential therapeutic strategy for type 2 diabetes.